MM-589 TFA |
Catalog No.GC65037 |
MM-589 TFA는 WD 반복 도메인 5(WDR5) 및 혼합 계통 백혈병(MLL) 단백질-단백질 상호작용의 강력한 억제제입니다. MM-589는 0.90nM의 IC50으로 WDR5에 결합하고 12.7nM의 IC50으로 MLL H3K4 메틸트랜스퍼라제 활성을 억제합니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2097887-21-1
Sample solution is provided at 25 µL, 10mM.
MM-589 TFA is a potent inhibitor of WD repeat domain 5 (WDR5) and mixed lineage leukemia (MLL) protein-protein interaction. MM-589 binds to WDR5 with an IC50 of 0.90 nM and inhibits the MLL H3K4 methyltransferase activity with an IC50 of 12.7 nM[1].
MM-589 (0.01-10 µM, 4 days or 7 days) potently and selectively inhibits cell growth in human leukemia cell lines harboring MLL translocations[1].
[1]. Karatas H, et al. Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)-Mixed Lineage Leukemia (MLL) Protein-Protein Interaction. J Med Chem. 2017 Jun 22;60(12):4818-4839.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *